NCT04059965

AntiCoagulation Tracking InterVention and Evaluation

AntiCoagulation Tracking InterVention and Evaluation: Using a Customized Panel Management Platform to Improve Outcomes for Patients on Anticoagulation

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of California, San Francisco · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Accepted

Summary

Anticoagulants are a leading cause of acute injury from adverse drug events, leading to \~20,000 serious injuries reported to the Food and Drug Administration per year and more than 220,000 emergency department visits annually. Therefore, we propose to implement a health information technology (HIT) population management tool at two distinct anticoagulation clinics that will allow the care team to assign and track tasks essential for timely patient monitoring. We will examine its effect on anticoagulation management outcomes through a randomized trial, hypothesizing that such interventions can be effective as well as cost-effective strategies to improve patient safety in the context of anticoagulation management services.

Conditions

• Anticoagulation
• Atrial Fibrillation
• Atrial Flutter
• Pulmonary Embolus/Emboli
• Deep Vein Thrombosis
• Stroke
• Hypercoagulability

Interventions

Type	Name	Description
OTHER	Panel Management for Anticoagulation Therapy	Patients in the intervention arm will receive notifications reminding them of upcoming labs and appointments. We hypothesize this will improve adherence and therapeutic control and reduce risk for bleeds and/or strokes
OTHER	Usual Care	Patients will receive standard, protocolized care in their respective anticoagulation clinics

Timeline

• Start date: 2022-10-01
• Primary completion: 2024-09-30
• Completion: 2025-09-30
• First posted: 2019-08-16
• Last updated: 2022-08-04